Search Results - Triebel, Frederic

Frédéric Triebel

Frédéric Triebel (born 20 November 1954) is a French immunologist who is best known for his 1990 discovery of the LAG3 immune control mechanism. Triebel worked through the 1990s in a collaboration between Institut Gustave Roussy and Merck Serono to establish LAG-3's mechanism of action in T cells and dendritic cells. In 2001 he founded Immutep SA, a biotech company, to develop the therapeutic potential of LAG3. In 2014 this company was acquired by Prima BioMed, where Triebel remains Chief Scientific and Medical Officer. Provided by Wikipedia
  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Paclitaxel plus Eftilagimod Alpha, a soluble LAG-3 protein, in metastatic, HR+ breast cancer: results from AIPAC, a randomized, placebo controlled phase IIb trial by Wildiers, Hans (Author) , Armstrong, Anne (Author) , Cuypere, Eveline (Author) , Dalenc, Florence (Author) , Dirix, Luc (Author) , Chan, Steve (Author) , Marmé, Frederik (Author) , Schröder, Carolina P. (Author) , Huober, Jens (Author) , Duhoux, Francois P. (Author) , Vuylsteke, Peter (Author) , Jager, Agnes (Author) , Brain, Etienne (Author) , Kuemmel, Sherko (Author) , Pápai, Zsuzsanna (Author) , Menke-van der Houven van Oordt, Catharina Willemien (Author) , Perjesi, Luca (Author) , Mueller, Christian (Author) , Brignone, Chrystelle (Author) , Triebel, Frederic (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:

Search Tools: